Peter Heerma is CCO & VP at Travere Therapeutics, Inc. (TVTX). They have made 15 open-market trades across 1 company since 2020, most recently 2026-09-17.
CIK 0001789617
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TVTX | 117,066 | $5.8M |
| RTRX | 42,329 | $1.0M |
| Total | $6.8M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TVTX | SELL · 10b5-1 | 2026-09-15 | 2026-09-17 | $63.06 | $17.9M | -7.0% | — | — |
| TVTX | SELL | 2026-05-05 | 2026-05-06 | $46.65 | $101K | -5.7% | +0.6% | +23.2% |
| TVTX | SELL | 2026-04-14 | 2026-04-15 | $41.93 | $303K | +2.5% | +6.9% | +43.3% |
| TVTX | SELL | 2026-02-03 | 2026-02-03 | $32.12 | $235K | -15.2% | -16.7% | +37.0% |
| TVTX | SELL · 10b5-1 | 2025-12-24 | 2025-12-29 | $40.00 | $199K | -10.4% | -21.6% | -28.4% |
| TVTX | SELL · 10b5-1 | 2025-10-31 | 2025-11-04 | $35.00 | $196K | +1.5% | +3.9% | -2.7% |
| TVTX | SELL · 10b5-1 | 2025-10-28 | 2025-10-30 | $30.00 | $80K | +4.4% | +1.7% | -12.5% |
| TVTX | SELL | 2025-05-05 | 2025-05-05 | $21.05 | $37K | +0.7% | -27.6% | -24.0% |
| TVTX | SELL · 10b5-1 | 2025-02-11 | 2025-02-12 | $24.08 | $198K | -10.5% | -14.4% | -9.2% |
| TVTX | SELL | 2025-02-03 | 2025-02-04 | $20.12 | $208K | +8.8% | -10.1% | +1.7% |
| TVTX | SELL | 2025-01-22 | 2025-01-23 | $18.94 | $30K | +0.7% | +1.3% | -20.3% |
| TVTX | SELL | 2024-09-09 | 2024-09-09 | $11.52 | $25K | +16.7% | +36.4% | +45.5% |
| TVTX | SELL | 2024-02-01 | 2024-02-02 | $8.53 | $36K | -0.8% | -1.6% | -26.0% |
| TVTX | SELL | 2024-01-23 | 2024-01-25 | $9.07 | $14K | -5.5% | -12.5% | -40.6% |
| TVTX | SELL | 2023-10-03 | 2023-10-04 | $8.25 | $26K | -7.5% | -10.1% | +23.4% |
| TVTX | SELL | 2023-02-01 | 2023-02-02 | $21.75 | $39K | -7.8% | +0.7% | -28.0% |
| TVTX | SELL | 2023-01-24 | 2023-01-26 | $21.90 | $34K | -0.2% | -0.5% | -5.6% |
| TVTX | SELL | 2022-10-04 | 2022-10-06 | $25.68 | $156K | -11.1% | -21.0% | -18.6% |
| TVTX | SELL · 10b5-1 | 2022-01-31 | 2022-02-02 | $27.40 | $31K | +9.3% | +2.7% | +0.3% |
| TVTX | SELL · 10b5-1 | 2022-01-24 | 2022-01-26 | $24.98 | $47K | +4.5% | +0.8% | -0.4% |
| TVTX | SELL | 2021-10-04 | 2021-10-05 | $24.77 | $151K | -1.8% | +23.8% | +22.6% |
| TVTX | SELL | 2021-08-17 | 2021-08-17 | $17.12 | $24K | +9.6% | +14.3% | +49.6% |
| TVTX | SELL · 10b5-1 | 2021-02-05 | 2021-02-09 | $31.50 | $71K | -0.9% | -3.9% | -33.8% |
| TVTX | SELL · 10b5-1 | 2021-02-02 | 2021-02-03 | $29.83 | $34K | -9.8% | -13.6% | -23.2% |
| RTRX | SELL · 10b5-1 | 2020-10-02 | 2020-10-05 | $19.13 | $84K | +4.4% | +4.4% | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.